| 91 |
Revisiting the management of chronic ITP; a randomized controlled clinical trial |
2020 |
| 92 |
Revisiting the management of chronic ITP; a randomized controlled clinical trial |
2020 |
| 93 |
Revisiting the management of chronic ITP; a randomized controlled clinical trial |
2020 |
| 94 |
Serum and urine monocyte chemoattractant protein-1 as a markers for lupus nephritis. |
2020 |
| 95 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 96 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 97 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 98 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 99 |
The associations among RARRES2
rs17173608 gene polymorphism, serum
chemerin, and non-traditional lipid profile
in patients with metabolic syndrome |
2020 |
| 100 |
The associations among RARRES2
rs17173608 gene polymorphism, serum
chemerin, and non-traditional lipid profile
in patients with metabolic syndrome |
2020 |